June 15, 2007 - Baxa Corporation recently announced the expansion of its Valimed System, which uses enhanced photoemission spectroscopy to quickly validate high-risk medication admixtures, as well as returned narcotics to provide an increased level of patient safety.
ValiMed compares a medication's spectroscopic signature to the Medication Signature Library and returns an easy-to-understand "validated" or "not validated" result, requiring no user interpretation.
The expanded ValiMed System features patented technology that validates in seconds compounded doses of high-risk medications prior to dispensing. Verification of compounding accuracy is a requirement under USP 27-NF 22 Chapter 797, which regulates the compounding of sterile products.
For more information: www.valimed.com